DoW Rare Cancers Idea Development Award
Defense Health Agency Contracting Activity - DHACA · Military Medical Research and Development (12.420)
Posted 17 Jun 2026 · 49 days left
Summary
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation.
Distinctive Features:
The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research.
Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study.
Research should have high potential impact on rare cancers and the patient community.
Excerpt from the donor's page. The full text, annexes and forms are on the original call.
Eligibility and conditions
Show the eligibility text from the source
Applicant types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"